PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine, Dentistry and Biomedical Sciences, Queen\'s University Belfast, Belfast, UK.\', \'School of Medicine, University of Central Lancashire, Preston, UK.\', \'Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'UCL Medical School, University College London, London, UK.\', \'Department of Cardiology, Manchester Royal Infirmary, Manchester, UK.\', \'Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK.\', \'Department of Cardiothoracic Surgery, Liverpool Heart and Chest, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/14656566.2021.1960311
?:hasPublicationType
?:journal
  • Expert opinion on pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34464223
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.909
?:rankingScore_hIndex
  • 67
is ?:relation_isRelatedTo_publication of
?:title
  • Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34464223>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34464223>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all